Compiled by the ENCLAI research team following a documented methodology · Editorial oversight: Dr Natalya Mathur, Founder · Data last updated: (UTC)

Invasive meningococcal disease in Singapore: 2026 cases and outbreak reports

Reported invasive meningococcal disease surveillance for Singapore (SGP) — — latest record 2026-11-03

What the 2026 data shows

As of 10 August 2026, Singapore has reported 2 invasive meningococcal disease cases in 2026, compiled from figures published by Singapore Communicable Diseases Agency (CDA). No 2025 figure has been reported.

Of the 21 countries reporting invasive meningococcal disease to ENCLAI in 2026, Singapore accounts for 0.1% of reported cases and ranks 20 by case count.

ENCLAI has logged 40 surveillance records for invasive meningococcal disease in Singapore in 2026, with the most detailed reporting in Jun 2026 (10 records). 4 of those arrived in the last 30 days; the case counts run to 2026-08-10. 1 distinct surveillance sources reported this pair in 2026.

Reporting authorities for these counts: Singapore Communicable Diseases Agency (CDA)

The daily disease brief

One email a day: what changed in official disease reporting worldwide, with the source named for every number. Reported facts only — no forecasts and no interpretation.

Double opt-in — we send a confirmation link and nothing else until you click it. One-click unsubscribe on every email. See our privacy notice.

Surveillance summary

2026 cases (YTD)
2
2025 cases (full year)
not reported
Baseline avg (3yr)
N/A
Trend (2025)
—
No 2025 figure

Reported cases by year, Singapore

YearReported casesShare of worldwide reports
2023 not reported —
2024 not reported —
2025 not reported —
2026 (year to date) 2 0.1%

Reporting bounds and case definitions vary; historical baselines are a separate comparison measure. Worldwide share compares this country's reported figure with the sum of all countries reporting invasive meningococcal disease to ENCLAI for that year. "Incomplete year" means our sources cover less than ten months of that year, so no full-year figure is shown; "outbreak total to date" is a running total since an outbreak began, not a count for one year.

Surveillance records logged in 2026

MonthRecordsReporting sources
Mar 202651
Apr 202631
May 202641
Jun 2026101
Jul 202641
Aug 202641
Sep 202651
Oct 202641
Nov 202611

A record is one dated surveillance publication or one row of an official table; a month with many records is a month with detailed reporting, not necessarily more cases. 4 records were logged in the last 30 days.

Invasive meningococcal disease in other countries, 2026

Country2026 casesTrend
Brazil 744 ▲ Rising · 2025
United States 516
Spain 221 ≈ Stable · 2025
Poland 125 ▲ Rising · 2025
Australia 103

Other diseases reported in Singapore, 2026

Disease2026 casesTrend
Dengue fever 2,865
Tuberculosis 2,861
Acute haemorrhagic conjunctivitis 1,245
Non-typhoidal salmonellosis 1,054
COVID-19 475

Questions about this page

How many invasive meningococcal disease cases has Singapore reported in 2026?
As of 10 August 2026, Singapore has reported 2 invasive meningococcal disease cases in 2026, compiled from figures published by Singapore Communicable Diseases Agency (CDA). No 2025 figure has been reported.
Where does Singapore publish invasive meningococcal disease surveillance data?
The counts on this page were published by Singapore Communicable Diseases Agency (CDA). ENCLAI compiles and normalises them and is not affiliated with these authorities.

About this data

Figures are reported case counts as published by the originating health authorities, compiled by ENCLAI from 444 verified surveillance sources. Singapore figures reflect the reporting available to ENCLAI; reporting periods and case definitions differ between sources, and a missing report does not establish zero cases. ENCLAI holds invasive meningococcal disease records for Singapore dated from 2025. How we verify and update data: methodology & Trust Center · understanding case counts.

Track invasive meningococcal disease in Singapore live — alerts, exports and sub-national drill-down: start a 7-day free trial or request a demo.

The daily disease brief

One email a day: what changed in official disease reporting worldwide, with the source named for every number. Reported facts only — no forecasts and no interpretation.

Double opt-in — we send a confirmation link and nothing else until you click it. One-click unsubscribe on every email. See our privacy notice.